LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.

Wei WQ, Li X, Feng Q, Kubo M, Kullo IJ, Peissig PL, Karlson EW, Jarvik GP, Lee MTM, Shang N, Larson EA, Edwards T, Shaffer CM, Mosley JD, Maeda S, Horikoshi M, Ritchie M, Williams MS, Larson EB, Crosslin DR, Bland ST, Pacheco JA, Rasmussen-Torvik LJ, Cronkite D, Hripcsak G, Cox NJ, Wilke RA, Stein CM, Rotter JI, Momozawa Y, Roden DM, Krauss RM, Denny JC
Circulation. 2018 138 (17): 1839-1849

PMID: 29703846 · PMCID: PMC6202211 · DOI:10.1161/CIRCULATIONAHA.117.031356

MeSH Terms (17)

Case-Control Studies Coronary Disease Databases, Genetic Dyslipidemias Electronic Health Records Gene Frequency Genetic Predisposition to Disease Genome-Wide Association Study Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Lipoprotein(a) Phenotype Polymorphism, Single Nucleotide Risk Assessment Risk Factors Time Factors Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: